INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,474,531 | -23.9% | 85,900 | -7.5% | 0.59% | -0.3% |
| Q2 2023 | $5,882,428 | +105.0% | 92,900 | +75.3% | 0.59% | +38.9% |
| Q1 2023 | $2,869,950 | -54.4% | 53,000 | -55.5% | 0.42% | -53.2% |
| Q4 2022 | $6,297,480 | -17.4% | 119,000 | -27.4% | 0.91% | +40.0% |
| Q3 2022 | $7,627,000 | -46.3% | 163,900 | -34.2% | 0.65% | -59.5% |
| Q2 2022 | $14,213,000 | +10.6% | 249,000 | +18.6% | 1.60% | +47.6% |
| Q1 2022 | $12,850,000 | – | 210,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |